Overview

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

Status:
RECRUITING
Trial end date:
2027-07-18
Target enrollment:
Participant gender:
Summary
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Phase:
PHASE3
Details
Lead Sponsor:
Zydus Therapeutics Inc.
Treatments:
saroglitazar